-
Cummins hails 'sharp' Australia as they get back to winning ways
-
'Keep up the spirit': Indonesian teenage 'Superman' joins wildfire fight
-
Bangladesh eye more Australia Tests to hit next level
-
Starc bags 10 as Australia thrash Bangladesh in second Test
-
Thousands expected at Sweden climate demo as election looms
-
Starc heroics see Australia thrash Bangladesh in second Test
-
Starc heroics put Australia on brink of victory over Bangladesh
-
Pegula dethrones Swiatek to book Cincy final against Gauff
-
Austrian mountain town finds niche in AI boom
-
South Korean survivor fights for workplace harassment 'justice'
-
Messi scores but Miami slump continues with loss to Toronto
-
Starc strikes as Bangladesh struggle to stay alive in 2nd Test
-
Sydney marathon unveils medal with wrong stadium
-
Prince Harry: royal misfit making unlikely UK return
-
Macron hosts Saudi's MBS for visit ranging from esports to Mideast
-
Blowing in the wind, humble balloon gets green makeover
-
Australia in control with 146-run first innings lead over Bangladesh
-
Pegula dethrones Swiatek to reach Cincinnati final
-
World No. 3 Pegula beats defending champ Swiatek to reach Cincy final
-
IndyCars zip among iconic Washington landmarks ahead of Freedom 250
-
Wyndham Clark surges clear at BMW Championship
-
Real Madrid snatch late win at Espanyol on Mourinho's return
-
Maresca says Man City must fill Rodri void after Barca switch
-
Real Madrid beat Espanyol in Mourinho's first game on return
-
Canada retaliates as trade war with US escalates
-
Olise helps Bayern past Dortmund in German Supercup
-
Fils dominates Cobolli to book Cincinnati final
-
Coach Rennie hails clinical All Blacks after Springboks Test win
-
Spurs lacked fight in dismal defeat at Brentford says De Zerbi
-
Charlton deliver blow to 'under pressure' Hammers boss Nuno
-
Inter thrash Monza to launch Serie A title defence
-
Carrick keeps calm despite Man Utd misery, big-spending Spurs crushed
-
Shambolic Spurs battered by Brentford
-
Canada's Carney stands up to Trump, despite risks
-
Pogacar wins Vuelta a Espana opening stage
-
Lens hammer Auxerre thanks to Thauvin penalty double
-
Clinical New Zealand shock wasteful South Africa in first Test
-
No singles for Serena, but she joins Alcaraz for US Open
-
Canada hits back with new tariffs after trade talks with US fail
-
Joao Pedro extends Chelsea stay with new long-term deal
-
Swedish police identify 17-year-old girl as victim in school sword attack
-
Yamaguchi to face An in hunt for fourth badminton world crown
-
Carrick keeps calm despite Man Utd misery, Sage beaten in first game as Palace boss
-
Norris clinches pole for Dutch GP
-
France to deliver interceptor missiles to Ukraine after new Russian strikes
-
Norris clinches pole for Dutch Grand Prix
-
Serena Williams and Alcaraz unite in US Open mixed doubles
-
Pope Leo calls for courage in Rimini visit after stop in tiny San Marino
-
Macron pledges air defence as 13 killed in Russia, Ukraine strikes
-
Man Utd must learn from 'frustrating' defeat at Hull: Carrick
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
P.Cavaco--PC